Luis Gonzales
Child & Adolescent Psychiatry · Bronx, NYNPI 1578641825
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,866 and has fallen 80.2% since, to $765 in 2025. Among child & adolescent psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $47.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Axsome Therapeutics, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$978
- AbbVie$815
- Alkermes, Inc.$784
- Sunovion Pharmaceuticals Inc.$567
- plus $4K from 14 others
What the payments were for
- Food & beverage$8,877100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $1,141 |
| Axsome Therapeutics, Inc. | 9 | $1,072 |
| Otsuka America Pharmaceutical, Inc. | 25 | $978 |
| AbbVie(2 entities) | 21 | $815 |
| Alkermes, Inc. | 12 | $784 |
| Sunovion Pharmaceuticals Inc. | 23 | $567 |
| Neurocrine Biosciences, Inc. | 8 | $565 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $514 |
| E.r. Squibb & Sons, L.L.C. | 5 | $441 |
| Teva Pharmaceuticals USA, Inc. | 11 | $398 |
| Lundbeck LLC | 22 | $370 |
| Indivior Inc. | 5 | $327 |
| Vanda Pharmaceuticals Inc. | 2 | $250 |
| Neuronetics, Inc. | 2 | $214 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $170 |
| Ironshore Pharmaceuticals Inc. | 1 | $125 |
| Acadia Pharmaceuticals Inc | 3 | $55 |
| Noven Therapeutics, LLC | 3 | $48 |
| Abbott | 1 | $23 |
| Novo Nordisk | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,370
- ARISTADA$1,000
- Auvelity$979
- REXULTI$596
- SPRAVATO$514
- VRAYLAR$479
- INGREZZA$478
- CAPLYTA$474
- COBENFY$383
- INVEGA SUSTENNA$355
- AUSTEDO$259
- ARISTADA INITIO$250
- Fanapt$250
- PERSERIS$247
- LATUDA$246
- INVEGA TRINZA$230
- NEUROSTAR TMS THERAPY SYSTEM$166
- ABILIFY MAINTENA$125
- Jornay PM 20mg capsules (Bottle of 100)$125
How this compares
$8,877 in reported general payments places this provider in the 95th percentile of 317 child & adolescent psychiatry providers in New York.
See all child & adolescent psychiatry providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 14 | $10,275 |
| AmbienZolpidem Tartrate | 12 | $7,238 |
| Lurasidone Hcl | 12 | $4,251 |
| Mirtazapine | 483 | $3,220 |
| Doxepin Hcl | 122 | $3,192 |
| Bupropion XlBupropion Hcl | 193 | $2,121 |
| Zolpidem Tartrate | 368 | $1,628 |
| Quetiapine Fumarate | 245 | $1,505 |
| Trazodone Hcl | 222 | $1,412 |
| Buspirone Hcl | 181 | $1,231 |
| Escitalopram Oxalate | 229 | $942 |
| Clonazepam | 191 | $756 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 60 | $739 |
| Aripiprazole | 56 | $632 |
| Memantine Hcl | 82 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $1,072 | $10,27514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 317 child & adolescent psychiatry providers in New York.
Other child & adolescent psychiatry in Bronx
- Hilda MascaroBronx$3K
- Aleksandra DjukicBronx$2K
- Matthew LorberNew York$398K
- Mitchell CabisudoNew Windsor$346K
- Parinda ParikhWhite Plains$185K
- Jeffrey NewcornNew York$165K
- John MarinoCanandaigua$70K
- Iliyan IvanovNew York$38K
- Melvin OatisNew York$35K
- Vijay PampanaMiddletown$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.